This work is licensed under the Creative Commons Attribution 4.0 International License.
Armengaud JB, Yzydorczyk C, Siddeek B, Peyter AC, Simeoni U. Intrauterine growth restriction: Clinical consequences on health and disease at adulthood. Reprod Toxicol. 2021 Jan;99:168–176. doi: 10.1016/j.reprotox.2020.10.005ArmengaudJBYzydorczykCSiddeekBPeyterACSimeoniUIntrauterine growth restriction: Clinical consequences on health and disease at adulthoodReprod Toxicol2021Jan9916817610.1016/j.reprotox.2020.10.005Open DOISearch in Google Scholar
Sharma D, Shastri S, Farahbakhsh N, Sharma P. Intrauterine growth restriction - part 1. J Matern Fetal Neonatal Med. 2016 Dec;29(24):3977–87. doi: 10.3109/14767058.2016.1152249SharmaDShastriSFarahbakhshNSharmaPIntrauterine growth restriction - part 1J Matern Fetal Neonatal Med2016Dec292439778710.3109/14767058.2016.1152249Open DOISearch in Google Scholar
Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM, et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost. 2005 Feb;93(2):228–35. doi: 10.1160/TH04-09-0578BlannADWoywodtABertoliniFBullTMBuyonJPClancyRMCirculating endothelial cells. Biomarker of vascular diseaseThromb Haemost2005Feb9322283510.1160/TH04-09-0578Open DOISearch in Google Scholar
Suparman E, Mose JC, Handono B, Khairini AF. The Difference in Endothelial Progenitor Cells (Epcs Cd34), Clotting Factors, Blood Pressure and Proteinuria among Preeclampsia Model Mice with and without the Administration of Epcs Cd34. Ann Rom Soc Cell Biol. 2021 May 5;25(5):1760–79. Available from: https://www.annalsofrscb.ro/index.php/journal/article/view/4699SuparmanEMoseJCHandonoBKhairiniAFThe Difference in Endothelial Progenitor Cells (Epcs Cd34), Clotting Factors, Blood Pressure and Proteinuria among Preeclampsia Model Mice with and without the Administration of Epcs Cd34Ann Rom Soc Cell Biol.2021May5255176079Available from: https://www.annalsofrscb.ro/index.php/journal/article/view/4699Search in Google Scholar
Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999 Aug 6;85(3):221–8. doi: 10.1161/01.res.85.3.221AsaharaTMasudaHTakahashiTKalkaCPastoreCSilverMBone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularizationCirc Res.1999Aug6853221810.1161/01.res.85.3.221Open DOISearch in Google Scholar
Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation. 2003 Jun 24;107(24):3059–65. doi: 10.1161/01.CIR.0000077911.81151.30StrehlowKWernerNBerweilerJLinkADirnaglUPrillerJEstrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formationCirculation.2003Jun241072430596510.1161/01.CIR.0000077911.81151.30Open DOISearch in Google Scholar
Patschan S, Tampe D, Müller C, Seitz C, Herink C, Müller GA, et al. Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation. BMC Musculoskelet Disord. 2016 Aug 12;17:339. doi: 10.1186/s12891-016-1197-2PatschanSTampeDMüllerCSeitzCHerinkCMüllerGAEarly Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiationBMC Musculoskelet Disord.2016Aug121733910.1186/s12891-016-1197-2Open DOISearch in Google Scholar
Luppi P, Powers RW, Verma V, Edmunds L, Plymire D, Hubel CA. Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci. 2010 Jul;17(7):643–52. doi: 10.1177/1933719110366164LuppiPPowersRWVermaVEdmundsLPlymireDHubelCAMaternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsiaReprod Sci2010Jul1776435210.1177/1933719110366164Open DOISearch in Google Scholar
Gussin HA, Bischoff FZ, Hoffman R, Elias S. Endothelial precursor cells in the peripheral blood of pregnant women. J Soc Gynecol Investig. 2002 Nov–Dec;9(6):357–61. doi: 10.1016/s1071-5576(02)00188-0GussinHABischoffFZHoffmanREliasSEndothelial precursor cells in the peripheral blood of pregnant womenJ Soc Gynecol Investig2002Nov–Dec963576110.1016/s1071-5576(02)00188-0Open DOISearch in Google Scholar
Sugawara J, Mitsui-Saito M, Hoshiai T, Hayashi C, Kimura Y, Okamura K. Circulating endothelial progenitor cells during human pregnancy. J Clin Endocrinol Metab. 2005 Mar;90(3):1845–8. doi: 10.1210/jc.2004-0541SugawaraJMitsui-SaitoMHoshiaiTHayashiCKimuraYOkamuraKCirculating endothelial progenitor cells during human pregnancyJ Clin Endocrinol Metab2005Mar9031845810.1210/jc.2004-0541Open DOISearch in Google Scholar
Van Craenenbroeck EM, Van Craenenbroeck AH, van Ierssel S, Bruyndonckx L, Hoymans VY, Vrints CJ, et al. Quantification of circulating CD34+/KDR+/CD45dim endothelial progenitor cells: analytical considerations. Int J Cardiol. 2013 Sep 1;167(5):1688–95. doi: 10.1016/j.ijcard.2012.10.047Van CraenenbroeckEMVan CraenenbroeckAHvan IersselSBruyndonckxLHoymansVYVrintsCJQuantification of circulating CD34+/KDR+/CD45dim endothelial progenitor cells: analytical considerationsInt J Cardiol.2013Sep1167516889510.1016/j.ijcard.2012.10.047Open DOISearch in Google Scholar
Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, et al. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1(Suppl 1): 3–57. doi: 10.1002/ijgo.13522MelamedNBaschatAYinonYAthanasiadisAMecacciFFiguerasFFIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restrictionInt J Gynaecol Obstet2021Mar152Suppl 1(Suppl 1)35710.1002/ijgo.13522Open DOISearch in Google Scholar
Cetin I, Alvino G. Intrauterine growth restriction: implications for placental metabolism and transport. A review. Placenta. 2009 Mar;30 Suppl A:S77–82. doi: 10.1016/j.placenta.2008.12.006CetinIAlvinoGIntrauterine growth restriction: implications for placental metabolism and transportA review. Placenta2009Mar30Suppl AS778210.1016/j.placenta.2008.12.006Open DOISearch in Google Scholar
Colombo E, Marconi C, Taddeo A, Cappelletti M, Villa ML, Marzorati M, et al. Fast reduction of peripheral blood endothelial progenitor cells in healthy humans exposed to acute systemic hypoxia. J Physiol. 2012 Feb 1;590(3):519–32. doi: 10.1113/jphysiol.2011.223032ColomboEMarconiCTaddeoACappellettiMVillaMLMarzoratiMFast reduction of peripheral blood endothelial progenitor cells in healthy humans exposed to acute systemic hypoxiaJ Physiol.2012Feb159035193210.1113/jphysiol.2011.223032Open DOISearch in Google Scholar
Mallucci G, Beneventi F, Bergamaschi R, Bizzotto C, Cavagnoli C, De Maggio I, et al. Circulating endothelial progenitor cells during pregnancy in multiple sclerosis. Neurol Sci. 2021 Apr;42(4): 1443–1451. doi: 10.1007/s10072-020-04648-3MallucciGBeneventiFBergamaschiRBizzottoCCavagnoliCDe MaggioICirculating endothelial progenitor cells during pregnancy in multiple sclerosisNeurol Sci2021Apr4241443145110.1007/s10072-020-04648-3Open DOISearch in Google Scholar
Mousavi SH, Abroun S, Zarrabi M, Ahmadipanah M. The effect of maternal and infant factors on cord blood yield. Pediatr Blood Cancer. 2017 Jul;64(7):e26381. doi: 10.1002/pbc.26381MousaviSHAbrounSZarrabiMAhmadipanahMThe effect of maternal and infant factors on cord blood yieldPediatr Blood Cancer2017Jul647e2638110.1002/pbc.26381Open DOISearch in Google Scholar
Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1572–9. doi: 10.1161/ATVBAHA.107.144972TimmermansFVan HauwermeirenFDe SmedtMRaedtRPlasschaertFDe BuyzereMLEndothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursorsArterioscler Thromb Vasc Biol2007Jul2771572910.1161/ATVBAHA.107.144972Open DOISearch in Google Scholar
Giordano D, Loddo S, Laganà AS, Coppolino G, Zoccali G, Di Benedetto A, et al. Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis. J Matern Fetal Neonatal Med. 2018 Jan;31(2):258–260. doi: 10.1080/14767058.2016.1277703GiordanoDLoddoSLaganàASCoppolinoGZoccaliGDi BenedettoAPeripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysisJ Matern Fetal Neonatal Med2018Jan31225826010.1080/14767058.2016.1277703Open DOISearch in Google Scholar
Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 2006; 20:E664–76.LiBSharpeEEMaupinABTeleronAAPyleALCarmelietPVEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularizationFASEB J.200620E66476Search in Google Scholar
Fischer C, Mazzone M, Jonckx B, Carmeliet P. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer. 2008 Dec;8(12):942–56. doi: 10.1038/nrc2524FischerCMazzoneMJonckxBCarmelietPFLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?Nat Rev Cancer.2008Dec8129425610.1038/nrc2524Open DOISearch in Google Scholar
Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007 Jan;112(1):51–7. doi: 10.1042/CS20060161WallnerWSengenbergerRStrickRStrisselPLMeurerBBeckmannMWAngiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restrictionClin Sci (Lond)2007Jan112151710.1042/CS20060161Open DOISearch in Google Scholar
Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, et al. Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod. 1998 Apr;4(4):377–86. doi: 10.1093/molehr/4.4.377BanksREForbesMASearlesJPappinDCanasBRahmanDEvidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1Mol Hum Reprod1998Apr443778610.1093/molehr/4.4.377Open DOISearch in Google Scholar
Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, et al. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol. 2012 Feb;206(2):163.e1–7. doi: 10.1016/j.ajog.2011.09.019BentonSJHuYXieFKupferKLeeSWMageeLACan placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?Am J Obstet Gynecol.2012Feb2062163.e1710.1016/j.ajog.2011.09.019Open DOISearch in Google Scholar
Sipos PI, Bourque SL, Hubel CA, Baker PN, Sibley CP, Davidge ST, et al. Endothelial colony-forming cells derived from pregnancies complicated by intrauterine growth restriction are fewer and have reduced vasculogenic capacity. J Clin Endocrinol Metab. 2013 Dec;98(12):4953–60. doi: 10.1210/jc.2013-2580SiposPIBourqueSLHubelCABakerPNSibleyCPDavidgeSTEndothelial colony-forming cells derived from pregnancies complicated by intrauterine growth restriction are fewer and have reduced vasculogenic capacityJ Clin Endocrinol Metab2013Dec981249536010.1210/jc.2013-2580Open DOISearch in Google Scholar
Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007 Mar 1;109(5):1801–9. doi: 10.1182/blood-2006-08-043471YoderMCMeadLEPraterDKrierTRMrouehKNLiFRedefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principalsBlood.2007Mar110951801910.1182/blood-2006-08-043471Open DOISearch in Google Scholar
King TF, Bergin DA, Kent EM, Manning F, Reeves EP, Dicker P, et al. Endothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk? J Clin Endocrinol Metab. 2013 Jan;98(1):E33–9. doi: 10.1210/jc.2012-2793KingTFBerginDAKentEMManningFReevesEPDickerPEndothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk?J Clin Endocrinol Metab.2013Jan981E33910.1210/jc.2012-2793Open DOISearch in Google Scholar
Monga R, Buck S, Sharma P, Thomas R, Chouthai NS. Effect of preeclampsia and intrauterine growth restriction on endothelial progenitor cells in human umbilical cord blood. J Matern Fetal Neonatal Med. 2012 Nov;25(11):2385–9. doi: 10.3109/14767058.2012.697228MongaRBuckSSharmaPThomasRChouthaiNSEffect of preeclampsia and intrauterine growth restriction on endothelial progenitor cells in human umbilical cord bloodJ Matern Fetal Neonatal Med2012Nov25112385910.3109/14767058.2012.697228Open DOISearch in Google Scholar
Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y, et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1451–5. doi: 10.1073/pnas.1011293108KumasawaKIkawaMKidoyaHHasuwaHSaito-FujitaTMoriokaYPravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse modelProc Natl Acad Sci U S A.2011Jan2510841451510.1073/pnas.1011293108Open DOISearch in Google Scholar
Chang JC, Chen YJ, Chen IC, Lin WS, Chen YM, Lin CH. Perinatal Outcomes After Statin Exposure During Pregnancy. JAMA Netw Open. 2021 Dec 1;4(12):e2141321. doi: 10.1001/jamanetworkopen.2021.41321ChangJCChenYJChenICLinWSChenYMLinCHPerinatal Outcomes After Statin Exposure During PregnancyJAMA Netw Open.2021Dec1412e214132110.1001/jamanetworkopen.2021.41321Open DOISearch in Google Scholar